President Trump signed an order dropping cannabis from Schedule I to Schedule III. What happens next is crucial. Most needed: ...

Though Trump's order marks the biggest shift in federal marijuana policy since 1970, the drug remains illegal in Wisconsin.

The researchers also examined potential health risks linked to cannabis use. Long-term data from adolescents suggested that ...

Marijuana is prescribed to help ease chronic pain and control nausea in cancer patients, but legal red tape has made more ...

The move to reclassify cannabis from a Schedule I to a Schedule III drug could spark new studies into pain, aging and women's health, Dr. Staci Gruber tells GBH's All Things Considered.

The order directs expedited rescheduling to Schedule III, but the same agency that's held up oral fluid testing for two years now holds the keys to marijuana testing's future.

The reclassifications of marijuana mark the biggest change to the federal legality of it since 1970. Here's what's happening.

The order’s introduction heavily emphasizes the need for scientific research to catch up to the real-world medical use of ...

New psychoactive substances, originally developed as potential analgesics but abandoned due to adverse side effects, may still have pharmaceutical value if researchers could nail down the causes of ...

WASHINGTON, DC / ACCESS Newswire / November 25, 2025 / As Congress moves decisively to eliminate intoxicating hemp products and President Trump prepares to announce a national cannabinoid regulatory ...

Editor's note: Este artículo está traducido al español. A provision tucked into the recent government funding bill could disrupt the sale of intoxicating, marijuanalike products that have proliferated ...